Frost & Sullivan
OCTOBER 3, 2024
billion by 2028 with a robust 18.3% billion by 2028, growing at 18.3% Unified Data Platforms: Market leaders are pushing to create platforms that integrate life science companies , labs, and pharmacies into the broader data aggregation ecosystem , allowing for a holistic view of the patient journey.
Frost & Sullivan
SEPTEMBER 2, 2024
billion by 2028, growing at a compound annual growth rate (CAGR) of 18.3% Beyond establishing data flow between patients, providers, and payers, market leaders and new entrants should expand their solutions to incorporate other key industry players, such as life science companies, laboratories, and pharmacies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frost & Sullivan
MAY 24, 2022
billion in 2028, with a compound annual growth rate of 40.1% This trend is continuing as companies innovate and invest more in emerging technologies. Frost & Sullivan expects the IaaS and Platform-as-a-service (PaaS) market in LATAM to increase from $7.3 billion in 2021 to $79.2 Edge Cloud Computing Growth.
Frost & Sullivan
FEBRUARY 27, 2025
The healthcare and life sciences industry is at a pivotal moment, poised for rapid transformation driven by groundbreaking advancements in technology, digital health, and personalized medicine. Want to dive deeper into transformative trends and uncover key growth opportunities in healthcare & life sciences?
Frost & Sullivan
MARCH 18, 2025
The Frost & Sullivan Healthcare and Life Sciences Experts had an exciting time engaging with industry pioneers and uncovering the latest innovations shaping the future of healthcare. Read Our Global Healthcare Data Interoperability Growth Opportunities Forecast to 2028. What Lies Ahead for Healthcare Digital Transformation?
Expert insights. Personalized for you.
52 
Let's personalize your content